<DOC>
	<DOCNO>NCT02704273</DOCNO>
	<brief_summary>This pre-Phase 1 prospective , non interventional clinical assessment study evaluate XLMTM subject age 3 year young . Many clinically relevant measure yet routinely assessed population may provide important insight natural history XLMTM future evaluation potential therapy .</brief_summary>
	<brief_title>A Clinical Assessment Study X-Linked Myotubular Myopathy ( XLMTM ) Subjects</brief_title>
	<detailed_description />
	<mesh_term>Muscular Diseases</mesh_term>
	<mesh_term>Myopathies , Structural , Congenital</mesh_term>
	<criteria>Subject diagnosis XLMTM result confirm mutation MTM1 gene Subject male Subject age less 4 year Subject require mechanical ventilatory support ( eg , range 24 hour per day full time mechanical ventilation , noninvasive support continuous positive airway pressure [ CPAP ] bilevel positive airway pressure [ BiPAP ] sleep hour ) Access subject 's medical record Signed informed consent parent ( ) legally authorize representative ( ) ( LAR ) ( applicable ) Subject parent ( ) LAR willing able comply study visit study procedure Subject participate interventional study design treat XLMTM Subject bear &lt; 35 week gestation still term per correct age Subject clinically important condition , lifethreatening disease XLMTM , opinion investigator Subject receive pyridostigmine medication treat XLMTM within 30 day enrollment</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>3 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>MTM</keyword>
	<keyword>XLMTM</keyword>
</DOC>